Trials show vaccine is safe


Posted on July 1st, by editor in Caring Times. No Comments

Initial results of a clinical trial of a potential vaccine for Alzheimer1s Disease have shown that it is safe and well-tolerated in humans. The World Alzheimer Congress 2000, held in Washington DC in July, heard that animal studies of the vaccine, AN-1792, confirmed that it leads to an immune response which increases the clearance of amyloid plaques from the brain and prevents additional plaques from forming. (Scientists believe that amyloid plaques, found in the brains of most individuals with AD, impede nerve cell function and cause cell death.) The researcher is Dale Schenk from Elan Pharmaceuticals, who said: “Amyloid plaques act as a brain invader. We are optimistic that we can attack this invader at its source and eventually help millions of people and families world wide.”





Comments are closed.


Latest blog posts

Extracare – the next best solution?

By Caring Times editor GEOFF HODGSON

Academics at Newcastle University say that an average of almost nine thousand more care home beds will be needed each...

Care homes discounted in end of life care

By Caring Times editor GEOFF HODGSON

I am sure that we all want those who we care for to experience ‘a good death’ when the time...

Perhaps I’m ‘app’athetic

By Caring Times editor GEOFF HODGSON

I’ve got an app in my toolbox that allows me to bang-in nails – I call it a hammer. I’ve...